Serum Metalloproteinases 2 and 9 as Predictors of Gait Status, Pressure Ulcer and Mortality after Hip Fracture

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Gumieiro, David N ^a   Rafacho, Bruna P M ^a   Gonçalves, Andrea F ^a   Santos, Priscila P ^a   Azevedo, Paula S ^a   Zornoff, Leonardo A M ^a   Pereira, Gilberto J C ^a   Matsubara, Luiz S ^a   Paiva, Sergio A R ^a   Minicucci, Marcos F ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GELATINASE A; GELATINASE B; LIPOCALIN;

AGED; ARTICLE; BLOOD SAMPLING; DECUBITUS; DEMOGRAPHY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; FEMUR INTERTROCHANTERIC FRACTURE; FEMUR NECK FRACTURE; FEMUR SUBTROCHANTERIC FRACTURE; GAIT; HIP FRACTURE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUTROPHIL; OPERATION DURATION; PREDICTION; PROSPECTIVE STUDY; ZYMOGRAPHY;

ACUTE-PHASE PROTEINS; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; GAIT; HIP FRACTURES; HUMANS; LENGTH OF STAY; LIPOCALINS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; PRESSURE ULCER; PROGNOSIS; PROSPECTIVE STUDIES; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS; RECOVERY OF FUNCTION; REGRESSION ANALYSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84874230579     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057424     Document Type: Article

References (29)

1. Lefaivre KA, Macadam SA, Davidson DJ, Gandhi R, Chan H, et al. (2009) Length of stay, mortality, morbidity and delay to surgery in hip fractures. J Bone Joint Surg(br 91: 922-927.
2. Dunbar MJ, Howard A, Bogosh ER, Parvizi J, Kreder HJ, et al. (2009) An AOA-COA symposium. Orthopaedics in 2020: Predictors of musculoskeletal needs. J Bone Joint Surg Am 91: 2278-2286.
3. El Maghraoui A, Ngbanda AR, Bensaoud N, Bensaoud M, Rezqi A, et al. (2012) Age-adjusted incidence rates of hip fractures between 2006 and 2009 in Rabat, Morocco. Osteoporos Int. doi: 0.1007/s00198-012-2061-3.
4. Hu F, Jiang C, Shen J, Tang P, Wang Y, (2012) Preoperative predictors for mortality following hip fractures surgery a systematic review and meta analysis. Injury 43: 676-685.
5. Lindholm C, Sterner E, Romanelli M, Pina E, Torra y Bou J, et al. (2008) Hip fracture and pressure ulcers the Pan-European Pressure Ulcer Study intrinsic and extrinsic risk factors. Int Wound J 5: 315-328.
6. Baumgarten M, Margolis D, Berlin JA, Strom BL, Garino J, et al. (2003) Risk factors for pressure ulcers among elderly hip fracture patients. Wound Repair Regen 11: 96-103.
7. Ladwig GP, Robson MC, Liu R, Kuhn MA, Muir DF, et al. (2002) Ratios of activated matrix metalloproteinase-9 to tissue inhibitor of matrix metalloproteinase-1 in wound fluids are inversely correlated with healing of pressure ulcers. Wound Repair Regen 10: 26-37.
8. Yager DR, Zhang LY, Liang HX, Diegelmann RF, Cohen IK, (1996) Wound fluids from human pressure ulcers contain elevated matrix metalloproteinase levels and activity compared to surgical wound fluids. J Invest Dermatol 107: 743-748.
9. Brew K, Dinakarpandian D, Nagase H, (2000) Tissue inhibitors of metalloproteinases: evolution, structure and function. BiochimBiophysActa 1477: 267-283.
10. Ortega N, Behonick D, Stickens D, Werb Z, (2003) How proteases regulate bone morphogenesis. Ann N Y AcadSci 995: 109-116.
11. Henle P, Zimmermann G, Weiss S, (2005) Matrix metalloproteinases and failed fracture healing. Bone 37: 791-798.
12. Ahmed SH, Clark LL, Pennington WR, Webb CS, Bonnema DD, et al. (2006) Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease. Circulation 113: 2089-2096.
13. EPUAP (European Pressure Ulcer Advisory Panel) (1999) Guidelines on treatment of pressure ulcers. EPUAP Rev 1: 31-33.
14. Tyagi SC, Matsubara L, Weber KT, (1993) Direct extraction and estimation of collagenase(s) activity by zymography in microquantities of rat myocardium and uterus. Clin Biochem 26: 191-198.
15. Beloosesky Y, Grinblat J, Pirotsky A, Weiss A, Hendel D, (2004) Different C-reactive protein kinetics in post-operative hip-fractured geriatric patients with and without complications. Gerontology 50: 216-222.
16. Gumieiro DN, Rafacho BPM, Gradella LM, Azevedo PS, Gaspardo D, et al. (2012) Handgrip strength predicts pressure ulcers in patients with hip fracture. Nutrition 28: 438-442.
17. Kurtinaitis J, Dadonienė J, Kvederas G, Porvaneckas N, Butenas T, (2012) Mortality after femoral neck fractures: a two-year follow-up. Medicina (Kaunas) 48: 145-149.
18. Shoda N, Yasunaga H, Horiguchi H, Matsuda S, Ohe K, et al. (2012) Risk factors affecting inhospital mortality after hip fracture. retrospective analysis using the Japanese Diagnosis Procedure Combination Database. BMJ Open 2, e000416, doi:10.1136/bmjopen-2011-000416.
19. Vidal EI, Moreira-Filho DC, Pinheiro RS, Souza RC, Almeida LM, et al. (2012) Delay from fracture to hospital admission: a new risk factor for hip fracture mortality? Osteoporos Int 23: 2847-2859.
20. Guo S, DiPietro LA, (2010) Factors affecting wound healing. J Dent Res 89: 219-229.
21. Trengove NJ, StaceyMC, Macauley S, Bennett N, Gibson J, et al. (1999) Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Rep Reg7: 442-452.
22. Wysocki AB, Staiano-Coico L, Grinnell F, (1993) Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. J Invest Dermatol 101: 64-68.
23. Utz ER, Elster EA, Tadaki DK, Gage F, Perdue PW, et al. (2010) Metalloproteinase expression is associated with traumatic wound failure. J Surg Res 159: 633-639.
24. Ma GF, Ali A, Verzijl N, Hanemaaijer R, TeKoppele J, et al. (2006) Increased collagen degradation around loosened total hip replacement implants. Arthritis Rheum 54: 2928-2933.
25. Yokohama Y, Matsumoto T, Hirakawa M, Kuroki Y, Fujimoto N, et al. (1995) Production of matrix metalloproteinases at the bone-implant interface in loose total hip replacements. Lab Invest 73: 899-911.
26. Wigner NA, Kulkarni N, Yakavonis M, Young M, Tinsley B, et al. (2012) Urine matrix metalloproteinases (MMPs) as biomarkers for the progression of fracture healing. Injury 43: 274-278.
27. Lauhio A, Hästbacka J, Pettilä V, Tervahartiala T, Karlsson S, et al. (2011) Serum MMP-8,-9 and TIMP-1 in sepsis: high serum levels of MMP-8 and TIMP-1 are associated with fatal outcome in a multicenter, prospective cohort study. Hypothetical impact of tetracyclines. Pharmacol Res 64: 590-594.
28. Szarvas T, Jäger T, Becker M, Tschirdewahn S, Niedworok C, et al. (2011) Validation of circulating MMP-7 level as an independent prognostic marker of poor survival in urinary bladder cancer. Pathol Oncol Res 17: 325-332.
29. Hansson J, Vasan RS, Ärnlöv J, Ingelsson E, Lind L, et al. (2011) Biomarkers of extracellular matrix metabolism (MMP-9 and TIMP-1) and risk of stroke, myocardial infarction, and cause-specific mortality: cohort study. PLoS One 6: e16185.